ARK Israel Innovative Technology ETF · $134M$9,025
IZRLIZRL vsIBBIBBiShares Biotechnology ETF · $11.4B$14,214
$10,000 five years ago, dividends reinvested · they hold 0.1% in common
IZRLMeasureIBB
Returns · dividends reinvested
−11.4%Year to dateJan 1 → Nov 4+31.1%
−7.2%1 yearTotal return+40.7%
+20.8%3 years · per year$10,000 became $17,630 · $19,707+25.4%
−2.0%5 years · per year$10,000 became $9,025 · $14,214+7.3%
Cost and income
0.49%Expense ratio$49 · $44 a year on $10k · lower is better0.44%
2.93%Trailing 12-mo yield$293 · $15 a year on $10k0.15%
Risk · past year
−19.1%Worst dropSmaller is better−9.6%
22.8%VolatilityLower is calmer22.8%
IZRLIBB Winner of the row, in its colourEach row: the bigger of the two fills its side
1–6IBB wins
End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns